Injectable testosterone is one of the most established ways to deliver TRT, but the practical details, where it's injected, how often, and what gets checked along the way, are often glossed over once a diagnosis is confirmed. This guide sets out exactly what to expect from injectable TRT: the injection itself, the frequency that comes with each product, what a typical appointment involves, and the side effects and monitoring that are specific to injections rather than other formulations such as gel.
How testosterone injections are given
Testosterone for TRT is injected deep into a large muscle, almost always the gluteal (buttock) muscle, using an intramuscular technique designed to let the oil-based preparation absorb slowly into the bloodstream. The three products most commonly used in UK practice are testosterone enanthate, Sustanon 250 and Nebido, and while the active hormone is identical across all three, the ester attached to it governs how the injection is administered and how often it needs repeating.
Many men on enanthate or Sustanon are taught to self-inject at home once a clinician has assessed suitability and demonstrated the technique, usually rotating between the buttock and thigh to reduce soreness at the injection site. Nebido is different: because of its larger volume and a rare reaction linked to the injection itself, it is usually given by a clinician in a clinical setting rather than self-administered. Needles, swabs and sharps disposal are supplied as part of a self-injection programme, and your clinician will talk you through technique, site rotation and what to do if you miss a dose before you inject unsupervised for the first time.
How often: every few weeks vs every few months
Injection frequency is determined entirely by the ester attached to the testosterone, which controls how quickly it's released from the injection site. Testosterone enanthate and Sustanon 250 are shorter-acting and are typically given every 2 to 3 weeks, spacing doses closely enough to avoid an uncomfortable dip before the next injection is due. Nebido takes the opposite approach: a first injection, a second at around 6 weeks to establish levels, then every 10 to 14 weeks once the interval has settled.
Neither schedule is simply a matter of preference, it follows directly from how each ester behaves in the body, and sticking to the prescribed interval (rather than letting it drift) is what keeps your levels predictable between blood tests. If an injection is missed or significantly delayed, your clinician should be told, since this can affect both your symptom control and the timing of your next monitoring blood test.
What happens at each injection appointment
If you self-inject at home, routine appointments are mostly about monitoring rather than the injection itself: a blood test to check your testosterone trough level, haematocrit and PSA where relevant, a brief review of how you've been feeling across the dosing cycle, and a check that your technique and site rotation are still comfortable. Any side effects, missed doses or changes to your health history are flagged here, since they can affect whether your current dose or interval still makes sense.
If you're on Nebido and attending in person for each injection, the appointment itself takes a little longer. Because the injection volume is larger, it's given slowly, over roughly a minute, and you'll typically be asked to stay for a short period afterwards so you can be monitored for any immediate reaction. This isn't a routine precaution taken for every injectable medicine, it's specific to how Nebido is administered, and it's one of the main practical reasons this particular product is given in a clinical setting rather than at home.
Side effects specific to injections
Some side effects of TRT are common across every formulation, but a few are more closely tied to how injections work:
- Injection site pain or soreness. This is common, usually mild, and tends to improve once you've established a rotation between sites.
- Acne or oilier skin. Reported by some men, often more noticeable around the peak of the dosing cycle.
- Fluid retention. Can occur, particularly early in treatment, and is something your clinician will ask about at review.
- Mood or energy changes around peaks and troughs. Shorter-acting esters such as enanthate and Sustanon produce a more noticeable rise shortly after injection and a gradual decline before the next dose, which some men notice as subtle shifts in mood, energy or libido across the cycle.
- Pulmonary oil microembolism (POME). A rare reaction specific to Nebido, causing coughing, breathlessness or dizziness in the minutes immediately after injection. It's uncommon, but it's the reason Nebido is injected slowly and under clinical supervision rather than self-administered.
Most of these settle with time or a small adjustment to dose, site or interval, and none of them should be managed by simply stopping or altering your injections yourself, rather than discussing them with your prescribing clinician.
Monitoring: haematocrit, PSA and levels
Injectable testosterone raises haematocrit, the concentration of red blood cells, more than gel-based TRT does, which is why a full blood count is checked regularly rather than left to a single baseline test. A haematocrit above 54% is generally a trigger for your clinician to act: that might mean reducing your dose, spacing out your injections, or, less commonly, arranging venesection (a blood draw to reduce red cell volume) if levels don't come down with dose changes alone.
PSA is also monitored, particularly in older men, as part of standard prostate safety checks rather than because testosterone is known to cause prostate cancer in men without pre-existing disease. Your testosterone level itself is measured as a trough, meaning the blood sample is taken just before your next injection is due, so what's being reviewed is your lowest point in the cycle rather than a peak shortly after a dose. Most UK clinicians follow a review pattern of around 3 months after starting or after a dose change, again at 6 months, then every 6 to 12 months once things are stable, rechecking testosterone, haematocrit and PSA where appropriate at each round.
When injections are not the right choice
Injections aren't the only route to TRT, and for some men they aren't the best fit. A strong needle phobia, discomfort with the idea of self-injecting, or a preference for a treatment you can stop applying on a given day rather than one already committed to your system for weeks, are all reasonable reasons to discuss a gel-based alternative with your clinician instead; our guide to testosterone gel for TRT covers how that compares. An already raised haematocrit, significant travel that makes clinic-based Nebido appointments impractical, or simply finding the peak-and-trough pattern of shorter-acting esters uncomfortable can also tip the decision towards a different formulation or schedule.
None of these are fixed rules, they're factors a clinician weighs against your diagnosis, lifestyle and blood results during your initial workup, covered in full in our guide to what happens at your first TRT consultation, and revisited at every review if your circumstances change. If you're still deciding whether TRT is the right step at all, our broader guide on whether TRT is safe sets out the benefits and risks side by side. Whichever formulation you start on, nothing about dose, interval or product should be changed without speaking to your prescribing clinician first.